Skip to main content
OpenTrials
Completed

NCT Number: NCT01593085

Evaluation of States in Major Depressive Patients With Cancer, Hospitalized in a Hospital Palliative

The investigators propose a study that aims to develop a methodology for assessing this risk and the psychological consequences of the malignancy in the palliative phase.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cancer Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Centre François BACLESSE

Caen, Calvados, 14076, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient (s) age (s) 18 or more
  • Patient (s) reach (s) of a cancer palliative stage
  • Patient (s) hospital (s) in the palliative care service
  • Patient (s) with cognitive function to an interrogation
  • Patient (s) having a physical condition for an interview lasting 45 minutes
  • Patient (s) that received clear information on the diagnosis and prognosis of their disease.
  • Free and informed consent signed

Exclusion criteria

  • Patient (s) age (s) under 18 years
  • Patient (s) under supervision or unable to give informed consent
  • Patient (s) whose cognitive functions do not allow an examination.

Treatment and study plan

interview with a doctor for evaluating suicide risk

Behavioral

patients with cancer in palliative cares An interview and will be offered to this patient during his hospitalization to be held (with the collection of personal and family psychiatric history of the patient, family and social context, the assessment of chronic pain and fatigue and quality of life,assessment of anxiety, Evaluation of symptoms of depression,asessment of suicide risk)

--------------------------------------------------------------------------------

Primary outcomes

  1. assessing the prevalence of suicide risk in patients with cancer admitted to a palliative care service.

    Time frame: at inclusion only, during hospitalization in palliative cares

    assessing the prevalence of suicide risk in patients with cancer admitted to a palliative care service.

Secondary outcomes

  1. Evaluate the feasibility of a methodology for estimating the risk of suicide in patients with cancer admitted to a palliative care service

    Time frame: at inclusion only, during hospitalization in palliative cares

    Evaluate the feasibility of a methodology for estimating the risk of suicide in patients with cancer admitted to a palliative care service Questionnaires used are HADS Questionary, Scale HAMILTON, Scale BECK and Scale DUCHER

  2. Assess the psychological impact of cancer pathology in patients in palliative

    Time frame: at inclusion only, during hospitalization in palliative cares

    Assess the psychological impact of cancer pathology in patients in palliative by evaluating depression score (with HADS HAMILTON, BECK, DUCHER scales)

  3. Identify risk factors for suicide in this patient population

    Time frame: at inclusion only, during hospitalization in palliative cares

    Identify risk factors for suicide in this patient population with evaluation of type of cancer, psychiatric history, family and social context, quality of life

Sponsors and collaborators

Lead sponsor

Centre Francois Baclesse

Other

Registry information

Acronym: DECAPAL

Important dates

Study start
2012
Primary completion
2013
Study completion
2013
First posted
May 7, 2012
Registry last updated
Feb 6, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.